Daiwa Securities Group
IPXL

Daiwa Securities Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Daiwa Securities Group’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-110,027
Closed -$5.05M – 1011
2015
Q2 		$5.05M Buy
+110,027
New +$5.22M 0.04% 194

Other funds holding IPXL

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Daiwa Securities Group's IPXL Position: Q3 2015 in Review

Daiwa Securities Group sold out of Impax Laboratories, Inc. (IPXL) in Q3 2015, closing a stake of 110,027 shares — an estimated $5.05M sold.

Daiwa Securities Group first reported a position in IPXL in Q2 2015 and held it in 1 quarter. The position peaked at $5.05M in Q2 2015. 195 funds tracked by Wall St. Rank hold IPXL as of Q3 2015.

  • Daiwa Securities Group reported no remaining Impax Laboratories, Inc. position as of Q3 2015 after selling out during the quarter.
  • Daiwa Securities Group sold 110,027 Impax Laboratories, Inc. shares in Q3 2015, an estimated $5.05M.
  • Daiwa Securities Group first reported a position in Impax Laboratories, Inc. in Q2 2015 and held it in 1 quarter.
  • Daiwa Securities Group's Impax Laboratories, Inc. position peaked at $5.05M in Q2 2015.
  • 195 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2015.

Based on Daiwa Securities Group's 13F filing for Q3 2015, filed 10 Nov 2015.